A tryptase test is a blood test that measures levels of tryptase, a protein released by mast cells (a type of immune cell involved in allergic reactions). It is primarily used to help confirm anaphylaxis after a severe allergic reaction, screen for a condition called systemic mastocytosis, and evaluate unexplained symptoms that may point to abnormal mast cell activity. Normal serum tryptase falls between 0 and 11.4 μg/L.
What Tryptase Tells You About Your Immune System
Tryptase is the most abundant protein stored inside mast cell granules. Mast cells are stationed throughout your body, especially in skin, airways, and the gut lining, where they act as first responders to allergens and infections. When mast cells activate, they release their stored contents in a process called degranulation. Tryptase spills into the bloodstream during this release, making it a reliable marker that mast cells have fired.
Because tryptase levels rise sharply when mast cells degranulate and then fall back down in a predictable pattern, a single blood draw can capture evidence of a reaction even after visible symptoms have resolved. That timing feature is what makes the test so useful in emergency and diagnostic settings.
Confirming Anaphylaxis
The most common reason for ordering a tryptase test is to confirm that an episode of anaphylaxis actually occurred. Anaphylaxis can look similar to severe asthma, heart attack, fainting disorders, or other types of shock, and no test available in real time during an emergency can distinguish between them. Tryptase drawn shortly after the event fills that gap.
Tryptase levels begin rising within 5 to 30 minutes of an anaphylactic reaction, peak around 30 minutes to 2 hours later, and return to baseline within 12 to 24 hours. The ideal window for drawing blood is 1 to 2 hours after symptoms start, and no later than 4 hours. Many guidelines recommend collecting samples at two or three time points: one as soon as possible, one at 1 to 2 hours to catch the peak, and a final draw at 24 hours to establish your personal baseline.
A result is considered significant if the acute level rises at least 20% above your baseline plus an additional 2 ng/mL. This “20+2 rule” is the current diagnostic standard for confirming mast cell activation. So if your baseline tryptase is 5 ng/mL, a reading above 8 ng/mL (5 × 1.2 + 2) during a reaction would support an anaphylaxis diagnosis. Without that baseline comparison, a single elevated number is harder to interpret, which is why the follow-up draw matters.
Screening for Systemic Mastocytosis
Systemic mastocytosis is a condition in which the body produces too many mast cells, and they accumulate in organs like the bone marrow, liver, or spleen. A persistently elevated baseline tryptase level, measured when you are not having any acute reaction, is one of the diagnostic clues. The consensus threshold is a baseline level above 20 ng/mL, which counts as a minor criterion for diagnosing the condition.
A diagnosis of systemic mastocytosis requires either one major and one minor criterion or three minor criteria. Tryptase alone does not confirm or rule out the disease, but it is one of the first screening tools used when a clinician suspects it. Once diagnosed, tryptase also serves as a monitoring marker: rising levels over time can signal disease progression, while stable or falling levels suggest the condition is under control.
Evaluating Mast Cell Activation Syndrome
Mast cell activation syndrome (MCAS) is a separate condition in which mast cells are normal in number but release their contents too easily or too often. Symptoms can include episodes of flushing, itching, low blood pressure, rapid heart rate, and gastrointestinal distress that seem to come out of nowhere. For MCAS to be diagnosed, clinicians look for severe, recurrent episodes involving at least two organ systems, along with a tryptase rise that meets the 20+2 rule during a flare compared to your personal baseline.
Because MCAS symptoms overlap with many other conditions, the tryptase test helps narrow the picture. A normal tryptase during a symptomatic episode does not completely exclude MCAS, but a documented rise during symptoms is strong supporting evidence.
Screening for Blood Disorders
Tryptase is not only relevant to allergic disease. It is also recommended as a screening tool when certain blood abnormalities are found but not yet explained, including unexplained low blood cell counts, high white blood cell counts, elevated platelets, or excess eosinophils or basophils. These findings can point toward myeloid neoplasms, a group of blood cancers that includes certain leukemias. Elevated tryptase in this context prompts further testing, such as bone marrow biopsy or genetic analysis.
During treatment for conditions like acute myeloid leukemia or chronic eosinophilic leukemia, tryptase can also be tracked over time to monitor the response to therapy.
Other Causes of Elevated Tryptase
An elevated result does not automatically mean anaphylaxis or mastocytosis. Chronic kidney disease can raise tryptase because the kidneys help clear it from the blood. Various blood cancers unrelated to mast cells can also push levels up. And a genetic trait called hereditary alpha-tryptasemia (HαT) causes a persistently high baseline without any disease at all.
HαT results from extra copies of a gene that encodes one form of tryptase. People with this trait produce more tryptase at rest, so their baseline sits above the standard reference range. HαT is found in roughly 4 to 6% of the general population and is even more common among people who also have systemic mastocytosis, affecting 12 to 21% of that group. When HαT is known or suspected, clinicians adjust the 20 ng/mL threshold accordingly to avoid a false diagnosis of mastocytosis.
This is one reason why knowing your personal baseline tryptase matters. A level of 15 μg/L might be entirely normal for someone with HαT but worth investigating in someone whose previous level was 4 μg/L.
How the Test Works
Tryptase is measured through a standard blood draw. No fasting or special preparation is needed, and you do not need to stop any medications beforehand. The sample is sent to a lab for analysis, and results typically come back within a few days, though turnaround varies by facility.
For suspected anaphylaxis, the timing of the draw is far more important than any preparation. Because tryptase has a half-life of roughly 1.5 to 2.5 hours, waiting too long after a reaction can produce a falsely normal result. If you have experienced a severe allergic episode in a hospital or clinic, the medical team will typically draw blood as soon as feasible and again at the 1 to 2 hour mark. A third sample at 24 hours captures your resting baseline for comparison.
For screening purposes, such as evaluating possible mastocytosis or unexplained symptoms, a single resting blood draw is sufficient. Ideally, this is done on a day when you are feeling well and have not had a recent allergic reaction, so the result reflects your true baseline.